AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (651)	9/3/1997 11:00:00 AM
From: MulhollandDrive	of 2173

Andrew, >>With AMLN and LGND, J and J wuld have a substantial position in a huge and lucractive market<< My thoughts exactly. J & J may prove to be the pure diabetes play if they indeed are covering all bases. As to the off topic business, I follow both AMLN and LGND. I have a rather diverse portfolio right now and monitor numerous threads, so would necessarily appreciate reducing redundancy. I still think Henry would be well served to start a thread on comparative analysis of both companies instead of posting LGND analysis here if he is so inclined. I understand the competitive/synergistic nature between the two companies and the reasoning for AMLN shareholders (as of this date, I am no longer one)to be informed about LGND's developments. However, feel that the best way of dealing with such would be another thread soley devoted to that issue. Regards, bp

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next